1. Rho YI, Chung HJ, Lee KH, Eun BL, Eun SH, Nam SO, Kim WS, Kim YO, Park HJ, Kim HS. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache 2012;52:592-599.
6. Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003;28:9-15.
7. Chung BY, Hong YL. Comparisons of Stressor and coping style between headache-suffering children and headache-free children. Korean J Child Health Nurs 2000;6:354-361.
8. Yoon JM, Lee HR, Lee KH. Characteristics of sleep disorders in childhood and adolescence. J Korean Child Neurol Soc 2007;15:185-191.
9. Rocha-Filho PA, Santos PV. Headaches, quality of life, and academic performance in schoolchildren and adolescents. Headache 2014;54:1194-1202.
10. Hong EY, Choi KY, Kim SK, Jung AY, Lee KH. Clinical characteristics and diagnoses for pediatric headache in the emergency department. Korean J Headache 2013;14:1-5.
11. Alfonzo M, Chen L. Acute migraine management in children. Pediatr Emerg Care 2015;31:722-727.
12. Nye BL, Ward TN. Clinic and emergency room evaluation and testing of headache. Headache 2015;55:1301-1308.
13. Richer L, Craig W, Rowe B. Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine. Headache 2014;54:1496-1505.
14. Richer L, Billinghurst L, Linsdell MA, Russell K, Vandermeer B, Crumley ET, Durec T, Klassen TP, Hartling L. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;4:CD005220.
15. Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache 2016;56:49-70.
16. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004;43:256-262.
18. Kabbouche M. Pediatric inpatient headache therapy: what is available. Headache 2015;55:1426-1429.
19. Sheridan DC, Meckler GD. Inpatient pediatric migraine treatment: does choice of abortive therapy affect length of stay. J Pediatr 2016;179:211-215.
22. Hickman C, Lewis KS, Little R, Rastogi RG, Yonker M. Prevention for pediatric and adolescent migraine. Headache 2015;55:1371-1381.
23. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40:539-549.
24. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004;44:230-237.
25. Kim H, Byun SH, Kim JS, Lim BC, Chae JH, Choi J, Kim KJ, Hwang YS, Hwang H. Comparison of flunarizine and topiramate for the prophylaxis of pediatric migraines. Eur J Paediatr Neurol 2013;17:45-49.
27. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF. PREEMPT Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921-936.